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Abstract
Background
Chronic Obstructive Pulmonary Disease (COPD) is associated with an increased risk of
myocardial infarction and stroke but it remains unclear how to identify microvascular
changes in this population.
Objectives
We hypothesized that simple non-mydriatic retinal photography is feasible and can be used
to assess microvascular damage in COPD.
Methods
Novel Vascular Manifestations of COPD was a prospective study comparing smokers with
and without COPD, matched for age. Non-mydriatic, retinal fundus photographs were
assessed using semi-automated software.
Results
Retinal images from 24 COPD and 22 control participants were compared. Cases were of
similar age to controls (65.2 vs. 63.1 years, p = 0.38), had significantly lower Forced Expira-
tory Volume in one second (FEV1) (53.4 vs 100.1% predicted; p < 0.001) and smoked more
than controls (41.7 vs. 29.6 pack years; p = 0.04). COPD participants had wider mean arteri-
olar (155.6 ±15 uM vs. controls [142.2 ± 12 uM]; p = 0.002) and venular diameters (216.8
±20.7 uM vs. [201.3± 19.1 uM]; p = 0.012). Differences in retinal vessel caliber were inde-
pendent of confounders, odds ratios (OR) = 1.08 (95% confidence intervals [CI] = 1.02,
1.13; p = 0.007) and OR = 1.05 (CI = 1.01, 1.09; p = 0.011) per uM increase in arteriolar and
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venular diameter respectively. FEV1 remained significantly associated with retinal vessel
dilatation r = -0.39 (p = 0.02).
Conclusions
Non-mydriatic retinal imaging is easily facilitated. We found significant arteriole and venous
dilation in COPD compared to age-matched smokers without COPD associated with lung
function independent of standard cardiovascular risk factors. Retinal microvascular changes
are known to be strongly associated with future vascular events and retinal photography
offers potential to identify this risk.
Trial registration
clinicaltrials.gov NCT02060292.
Introduction
Chronic obstructive pulmonary disease (COPD) is the 4th leading cause of death globally. In
the UK, over one million people are diagnosed with COPD and an estimated further 2 million
are affected [1]. COPD is frequently associated with co-morbidities such as cardiovascular dis-
ease, renal insufficiency, depression and osteoporosis, leading to the widely accepted view that
COPD is a complex, multi-system disorder [2].
There is a high prevalence of traditional cardiovascular risk factors in patients with COPD
including smoking, reduced physical activity and low socio-economic status. However, tradi-
tional cardiovascular risk factors do not appear to fully explain these findings, as numerous
studies have shown airflow limitation to be independent of cardiovascular disease risk [3].
Patients with COPD have a significantly increased risk of cardiac events and stroke, particu-
larly in early disease [4] and it is cardiovascular, not respiratory disease that is the leading
cause of death and contributor to vascular comorbidities [5].
Smoking is a significant risk factor for COPD contributing to many of these associated
complications with subsequent implications for the vasculature, blood pressure, and renal
function, through oxidative stress, endothelial dysfunction, hypoxaemia and autonomic dysre-
gulation [3, 6]. Nevertheless, mechanisms independent of smoking are also likely to be impor-
tant in the disease process, manifesting in increased inflammation of the systemic circulation
and contributing to the onset and progression of multiple comorbidities [7]. However, the
extent of microvascular damage in COPD independent of smoking, remains unclear.
The Novel Vascular Manifestations of COPD (NOVASC) study provided detailed assess-
ment of vascular pathology in COPD and age matched smokers without COPD [8]. Partici-
pants had brain and cardiac magnetic resonance imaging (MRI), in addition to measures of
arterial stiffness and retinal photography. Arterial stiffness is a non-invasive measure of vascu-
lar function and a strong predictor of cardiovascular and cerebrovascular events leading to
end-organ vascular damage through reduced vessel compliance, excessive pressure pulsatility
resulting in vascular remodelling and impaired blood flow [9–10]. There is evidence of
increased aortic stiffness in COPD independent of smoking, which is also associated with
degree of airflow limitation and percentage emphysema on thoracic computed tomography
[11].
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Microvascular retinopathy is a strong predictor of both cardiac events and stroke in the
general population and can be visualized through retinal fundus photography with high preci-
sion. Microvascular retinopathy is also associated with stroke independent of hypertension
and may be useful for studying subclinical cerebrovascular disease [12]. In the large U.S. popu-
lation based Multi Ethnic Study of Aging (MESA), arteriolar narrowing was independently
associated with risk of stroke over 6 years follow up (hazard ratio [HR] = 3.01; 95% confidence
intervals [CI]: 1.29–6.99) [13]. In the prospective Rotterdam study, retinal venular dilatation
was independently associated with an increased risk of dementia over an 11 year follow up
(HR = 1.31; 95% CI: 1.06–1.64) [14].
Retinal fundus photography offers an assessment of microvascular damage and offers an
opportunity to improve our understanding of the mechanisms of microvascular pathology in
COPD, identify patients with increased risk of future vascular events and a potential outcome
measure for future intervention studies in COPD. To our knowledge, previous investigation of
the retinal microvasculature in patients with COPD has been limited. A previous study
reported significant associations between larger venular caliber and lower forced expiratory
volume measured in one second (FEV1) and with lung density (p< 0.05) [15], while another
investigation identified COPD as an independent determinant of microvascular retinopathy
which correlates with disease severity and smoking status [16]. The factors that affect micro-
vascular efficacy are complex, but the elevated risk of cardiac events that are associated with
hypertensive/microvascular retinopathy and venular dilatation have been demonstrated [17].
Consequently, non-invasive measurement of the small vessel characteristics visualized in
the retina provides a proxy for direct examination of the general microvasculature. We
hypothesized that standard non-mydriatic retinal photography may provide evidence of
microvascular damage in age-matched smokers with and without COPD. Therefore, we
designed an observational case-controlled study and performed routine non-mydriatic retinal
photography in patients with COPD as well as a control group of age and gender matched
smokers. Our study achieved our aim by demonstrating that this form of retinal photography
is feasible, and that there is significant retinal arteriolar and venular dilation in COPD com-
pared to matched controls independent of potential confounders such as age, gender, smoking
status, and cardiac risk factors such as MSBP, PWV and antihypertensive medications.
Materials and methods
Study design
This was an observational case-control study called the novel vascular manifestations of
COPD (NOVASC) with patients recruited and all data collected over 12 months (January
2014- January 2015). The control group were age and gender matched without COPD. The
NOVASC study sample size calculation was made in relation to the primary outcome of
microstructural brain changes on MRI, for a conservatively estimated effect of d = 0.8, a sam-
ple of N = 30 compared against a sample of N = 25 will have in excess of 85% power
(beta < 0.10) using alpha = 0.05, two-sided. Retinal analysis was informed by past empirical
evidence and scientific reasoning and determined on feasibility and economic grounds and
are comparable with past similar research [8]. Gradable retinal images of sufficient quality for
vessel assessment were available in 46 participants. 1.0).
Ethical approval
Ethical approval was given by the National Research Ethics Service Committee South West–
Frenchay on 09/01/2014.
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Participants
The NoVasC study was designed to address the end organ impact of vascular pathology in
COPD through direct comparison of COPD patients and smoking no disease controls.
Recruitment of participants through GP practices in the Bristol area included individuals with
COPD (aged > 40 and� 85 years) diagnosed when the ratio of FEV1 to forced vital capacity
(FVC) < 70%, without increase following bronchodilator treatment [18] and a smoking his-
tory of> 10 cigarette pack years. Study participants were not excluded for other diseases influ-
encing retinal microvascular circulation such as diabetes or arterial hypertension. A gender
and age matched control group was recruited from university non-healthcare staff and
through local press advertisements. Controls were excluded if they had any self-reported mem-
ory difficulties or doctor-diagnosed respiratory disease. All participants provided written con-
sent before inclusion into the study. The healthcare professional who was taking consent
assessed capacity to understand, retain and recall information pertaining to consent. Addi-
tional exclusion criteria included where vessel caliber in the retinal images were ungradeable.
Clinical features
Cognitive function was assessed using the Montreal Cognitive Assessment (MoCA) [19] other
demographic and disease severity measures included a detailed medical history; arterialized
earlobe capillary or radial artery blood gases whilst breathing room air; vital signs including
oxygen saturation, heart rate, respiratory rate; health status questionnaire—COPD Assessment
Test (CAT) [20]; and spirometry according to the American Thoracic Society/ European
Respiratory Society guidelines [21]. Study visits took place at the Respiratory Research Unit,
North Bristol Lung Centre.
Retinal imaging and quantitative measurements of retinal
microvasculature
Participants underwent retinal color fundus photography. Retinal imaging took place at North
Bristol medical illustration. A standard 450 image was taken of each eye, with at least one
image centered on the optic disc and the other on the macula. All retinal images were anon-
ymized and examined. A trained grader who was proficient in the Singapore I Vessel Assess-
ment (SIVA) at the Centre for Public Health (Queen’s University Belfast), masked to protect
patient identity, used a standardized protocol to measure the retinal vessel caliber [22]. This
was performed using the SIVA, a semi-automated computer assisted programme (version 3.0)
to quantitatively measure retinal vascular parameters. The software automatically identifies the
optic disc, centering a grid on it, calculating the retinal vascular parameters and identifying the
vessel type. The measured area was standardized and defined within the region between 0.5
and 2.0 disc diameters away from the disc margin, and all visible vessels coursing through the
specified zone were measured (Fig 1).
Retinal vascular calibre. The retinal arteriolar and venular calibers were summarized as
central retinal arterial equivalent (CRAE) and central retinal venular equivalent (CRVE),
respectively, according to the revised Knudtson-Parr-Hubbard formula [23]. The reproduc-
ibility of retinal vascular measurements was high, with a high intragrader reliability and an
intraclass correlation coefficient previously reported calculated as 0.98 (CI: 0.97–0.98) for
CRAE and 0.99 (CI: 0.99–0.99) for CRVE, respectively [22]. A high correlation between the
right and left eyes in retinal vascular measurements has also been reported elsewhere [24].
Data from the right eye were used and when unavailable was replaced by left eye data.
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Retinal vascular fractal dimension. Total, arteriolar, and venular fractal dimensions
were determined from a skeletonized line tracing using the box counting method. These values
represent a “global” summary measure of the whole branching pattern of the retinal vascular
tree with larger values indicative of a more complex branching pattern [25].
Retinal vascular tortuosity. Retinal vascular tortuosity was estimated as the integral of
the curvature square along the path of the vessel normalized by the total path length; this mea-
sure is dimensionless because it represents a ratio measure [26]. These estimates were
Fig 1. Retinal fundus image quantitatively assessed using the Singapore I Vessel Analyzer (SIVA) software. Arterioles are coloured red and venules in blue. The
measurement region for retinal vascular parameters (caliber, fractal dimension, tortuosity and branching angle) was standardised from 0.5 to 2.0 optic disc diameters
from the disc margin.
https://doi.org/10.1371/journal.pone.0227175.g001
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summarized separately as retinal arteriolar and venular tortuosity [26]. Retinal vascular tortu-
osity reflects the straightness/waviness of the vessels; a smaller tortuosity value is indicative of
a retinal vessel with a straighter path.
Retinal vascular branching angle. Retinal vascular branching angle was defined as the
first angle subtended between two daughter vessels at each vascular bifurcation [27]. These
estimates were summarized as retinal arteriolar branching angle and retinal venular branching
angle, representing the average branching angle of arterioles and venules, respectively.
Other variables. Additional potential confounders were also considered within the condi-
tional regression models: age; gender; smoking (pack years); mean systolic blood pressure
(MSBP), PWV and anti-hypertensive medication.
Statistical analysis
All statistical analyses were performed using IBM SPSS statistics version 21 (IBM Corp.,
Armonk, NY). An independent t test or χ2 test was used to compare the characteristics of
COPD cases and controls in the study. Quantitative retinal vascular parameters were ana-
lyzed as continuous variables (and were standardized before entry into regression models to
give estimates per standard deviation [SD] increase). Logistic regression models were used to
analyze the association of retinal vascular parameters with COPD. Multiple logistic regres-
sion models were adjusted initially for age and gender (model 1), model 1 covariates and
MSBP, smoking (measured in pack years)–model 2; and model 2 covariates with PWV and
antihypertensive medication–model 3. Pearson’s correlation coefficient was used to calculate
r value between lung function (FEV1) and retinal measures, adjusted for age, gender and
smoking.
Results
Clinical features
Table 1 shows the summary characteristics of the COPD (n = 24) and control (n = 22) groups.
The COPD participants had an average age of 65 years (range 50–78) and 54% (13) were male
(Table 1). The control group (no COPD) was not significantly different in age to the COPD
group with a mean age of 63 years (range 44–79). Cases had significantly lower (P< 0.001)
mean FEV1 (%) (1.43; SD = 0.52) compared to controls (2.64; SD = 0.91) and FEV FVC (52.1
[12.7] versus 75.9 [9.9]). Cases were also more likely to be heavier smokers than controls (41.7
[20.8] pack years versus 29.6 [16.9]; P = 0.04). There were no significant differences between
cases and controls in the other parameters measured.
Gradable retinal images of sufficient quality for vessel assessment were available in 46 of the
51 participants. Table 2 shows the comparisons of retinal parameters between the COPD and
control groups. Smokers with COPD had significantly wider mean arteriolar caliber (155.6
±15 μM) versus no disease controls (142.2 ± 12 μM); p = 0.002 and mean venular diameters
(216.8 ±20.7 μM vs. 201.3± 19.1 μM): p = 0.012. No significant variations in arteriolar or venu-
lar fractal dimension, branching angles or tortuosity were detected in both unadjusted and
adjusted analyses between groups (P > 0.05).
In multivariate logistic regression, persons with larger arteriolar (OR per SD increase, 4.02
[CI: 1.54–10.5]) and venular caliber (OR per SD increase, 2.91 [CI: 1.16–7.33]) were more
likely to have COPD following adjustment for age, gender, smoking status (pack years), PWV,
MSBP and antihypertensive medication (Table 3, model 3). When controlling for age, gender,
BP, smoking (pack years), the association between FEV1% predicted (combined arteriolar and
venular) retinal vessel dilation was r -0.389 (p = 0.02).
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Discussion
This study has demonstrated that routine non-mydriatic retinal photography is feasible in
COPD and that there is significant retinal arteriolar and venular dilation in COPD compared
to matched controls independent of potential confounders such as age, gender, smoking sta-
tus, and cardiac risk factors such as MSBP, PWV and antihypertensive medications (P< 0.05).
Table 1. Summary characteristics of participants.
Characteristic Cases, n = 24 Controls, n = 22 P
Mean age, yrs (SD) 65.2 (7.0) 63.1 (8.9) 0.38
Mean MOCAa (SD) 25.9 (2.8) 27.0 (2.3) 0.17
Male, n (%) 13 (54) 10 (45) 0.56
Mean SBP, mmHg (SD) 143 (18) 143 (17) 0.90
Smoking, mean pack years (SD) 41.7 (20.8) 29.6 (16.9) 0.04
Body Mass Index, kg/m2 (SD) 28.3 (5.4) 27.0 (5.4) 0.41
Mean FEV1
b (SD) 1.43 (0.52) 2.64 (0.91) <0.001
Mean FEV1 FVC
c (SD) 52.1 (12.7) 75.9 (9.9) <0.001
Mean eGFRd, ml/min/1.73m2 (SD) 73.3 (17.6) 77.2 (10.1) 0.27
Mean Albumin, mmol/l (SD) 37.2 (2.7) 35.2 (11.2) 0.42
Mean C reactive protein, mmol/l (SD) 5.43 (5.36) 6.68 (11.9) 0.65
Mean Pulse wave velocity, m/s (SD) 10.6 (2.9) 11.0 (3.4) 0.67
Antihypertensive medication, n (%) 5 (21) 5 (23) 0.94
a Montreal Cognitive Assessment
b Forced expiratory volume in one second
c Ratio of FEV1 to forced vital capacity
d Estimated glomerular filtration rate
https://doi.org/10.1371/journal.pone.0227175.t001
Table 2. Comparisons of retinal vascular parameters between COPD cases and controls.
Parameter COPDa cases, n = 24 Controls, n = 22 Pb
Mean (SDc) Mean (SD)
Caliber
Central retinal arteriolar equivalent, μm 155.6 (15.0) 142.2 (12.0) 0.002
Central retinal venular equivalent, μm 216.8 (20.7) 201.3 (19.1) 0.012
Fractals
Total fractal dimension 1.366 (0.043) 1.365 (0.064) 0.921
Arteriolar fractal dimension 1.164 (0.052) 1.173 (0.066) 0.604
Venular fractal dimension 1.149 (0.049) 1.138 (0.067) 0.531
Tortuosity
Arteriolar tortuosity (x104) 0.697 (0.210) 0.639 (0.132) 0.275
Venular tortuosity (x104) 0.709 (0.220) 0.644 (0.164) 0.264
Bifurcations
Arteriolar branching angle, ˚ 79.44(12.89) 77.62 (19.00) 0.703
Venular branching angle, ˚ 78.22 (12.86) 75.33 (27.04) 0.641
a Chronic obstructive pulmonary disease
b P values were calculated by independent sample t test.
c Standard deviation
˚degree
https://doi.org/10.1371/journal.pone.0227175.t002
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Microvascular dilatation has been reported previously in smokers, both in healthy people with-
out overt cardiovascular or metabolic disease [28] and in persons with COPD [16]. It is also
consistent with the MESA lung epidemiology study which reported associations between
larger venular (not arteriolar) caliber and lower FEV1 and lung density [15]. The significance
of smoking is complex, often manifesting in long-term consequences for microvascular sys-
tems. It contributes to elevated cardiovascular and renovascular risk with venular dilatation
resultant from toxin-induced endothelial damage, moderated vasoactive intermediaries, tissue
hypoxaemia and autonomic dysregulation [3, 6], suggesting venular widening may lead to
lower oxygen saturation [29]. Retinal vascular caliber may revert to normal after a specific
period of time of sustained smoking cessation [30]. As such, retinal venular caliber could
become a useful tool to monitor and estimate COPD risk.
The correlation of microvascular abnormalities in COPD patients has been recently
reviewed by Vaes and colleagues in 2018 [31]. Peripapillary choroidal thickness in COPD
patients has been examined in three studies [32–34]. Ozcimen and colleagues found that the
COPD patients had significantly thinner peripapillary choroid in the inferior segments com-
pared to other peripapillary choroid segments and thinner than the controls [32]. Choroidal
thinning in COPD may be due to vascular endothelial dysfunction and hypoxia, which can
make the choroid more susceptible to diseases in the retina [32], and systemic microvascular
Table 3. Associations between COPD and retinal vascular parameters.
Parameter Model 1 Model 2 Model 3
ORa (95% CIc); Pb OR (95% CI); P OR (95% CI); P
Caliber
Central retinal arteriolar equivalent per SD
increase
2.99 (1.36–6.60);
0.006
3.39 (1.41–8.17);
0.007
4.02 (1.54–10.5);
0.005
Central retinal venular equivalent per SD
increase
2.89 (1.27–6.57);
0.012
3.01 (1.26–7.23);
0.013
2.91 (1.16–7.33);
0.023
Fractals
Total fractal dimension per SD increase 1.10 (0.59–2.02);
0.768
1.12 (0.58–2.17);
0.734
1.17 (0.57–2.37);
0.670
Arteriolar fractal dimension per SD increase 0.89 (0.48–1.65);
0.713
0.98 (0.50–1.90);
0.940
1.04 (0.52–2.11);
0.908
Venular fractal dimension per SD increase 1.28 (0.69–2.36);
0.437
1.14 (0.59–2.23);
0.692
1.13 (0.56–2.26);
0.729
Tortuosity
Arteriolar tortuosity per SD increase 1.40 (0.73–2.67);
0.307
1.83 (0.85–3.94);
0.120
2.13 (0.93–4.91);
0.075
Venular tortuosity per SD increase 1.42 (0.72–2.78);
0.314
1.55 (0.76–3.17);
0.229
1.51 (0.72–3.18);
0.275
Bifurcation
Arteriolar branching angle per SD increase 1.14 (0.62–2.11);
0.666
0.94 (0.47–1.87);
0.863
0.99 (0.49–2.03);
0.990
Venular branching angle per SD increase 1.13 (0.61–2.08);
0.704
0.97 (0.51–1.83);
0.921
1.02 (0.53–1.96);
0.955
Model 1 was adjusted for age and gender. Model 2 was adjusted for age, gender, mean systolic blood pressure,
smoking status (pack years). Model 3 was adjusted for model 2 covariates, pulse wave velocity and antihypertensive
medications.
a Odds ratio
c Confidence intervals
b P values
https://doi.org/10.1371/journal.pone.0227175.t003
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disorders [35]. However, there was no difference in the mean peripapillary and subfoveal cho-
roidal thickness in COPD compared to controls [32].
The strengths of this study are in its comprehensive assessment of vascular pathology in a
well characterized population of patients with COPD and the use of a healthy smoking control
group to help determine the contribution of COPD specific effect on vascular damage. We used
a readily available direct measure of microvascular damage assessed with validated software.
The images were collected in a ‘real world’ clinical environment without specialist training or
the need for mydriatic eye drops. However in this detailed mechanistic study, participant num-
bers were small limiting definitive conclusions to be made regarding the presence or absence of
association between retinal vascular features and disease and demographic measures. In addi-
tion, there may be residual confounding factors not measured in our sample or considered in
our data. Any causal and temporal relationships between vessel caliber and COPD cannot be
determined due to the cross-sectional nature of our study, which prevents the inference of any
causal relationship. We therefore restrict our conclusions to those associations that remain sig-
nificant after comprehensively controlling for confounders. For the results that indicated no sig-
nificant association, type II error may occur as the study power was limited by the number of
events and the number of potential confounders included within the statistical models. There
are also some conditions that may potentially influence the microvasculature of the retina. Spe-
cifically, the narrowing of the retinal arterioles are independent predictors of incident diabetes
mellitus, coronary heart disease and hypertension, while the widening of retinal venules has
been associated with incident cardiovascular disease [36–39].
In summary, our data provides evidence of significant retinal arteriolar and venous dilata-
tion in COPD compared to age-matched smokers without COPD. These differences are not
fully explained by standard cardiovascular risk factors, including smoking, and are associated
with lung function. The ability of venular dilatation to predict cardiac events and stroke have
been demonstrated in the non-COPD population [17]. Retinal microvascular measures can be
feasibly collected in clinic and offer the opportunity to identify future vascular events associ-
ated with COPD. Further longitudinal studies would be valuable in establishing if this is the
case and evaluation of the sensitivity and specificity of the microvascular changes detected.
The integrity of the microvasculature is extremely complex and a variety of risk factors influ-
ence the retinal arteriolar and venular bed, which may provide differential prognostic signifi-
cance for both systemic and chronic diseases.
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